Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2006 | 03-2006 | 12-2005 | 09-2005 | 06-2005 | |
| Sales | 510,356 | 407,233 | 418,813 | 410,296 | 416,266 |
| Cost of Goods | 330,860 | 234,754 | 223,442 | 210,809 | 211,213 |
| Gross Profit | 179,496 | 172,479 | 195,371 | 199,487 | 205,053 |
| Operating Expenses | 210,841 | 138,441 | 165,765 | 136,924 | 140,925 |
| Operating Income | -30,485 | 34,792 | 30,048 | 63,372 | 64,341 |
| Interest Expense | 3,322 | 3,301 | 2,920 | 4,690 | 3,624 |
| Other Income | 8,669 | 9,047 | 4,540 | 3,668 | 3,734 |
| Pre-tax Income | -25,138 | 40,538 | 31,668 | 62,350 | 64,451 |
| Income Tax | -9,527 | 15,364 | 11,259 | 23,264 | 24,002 |
| Net Income Continuous | -15,611 | 25,174 | 20,409 | 39,086 | 40,449 |
| Net Income | $-15,611 | $25,174 | $20,409 | $39,086 | $40,449 |
| EPS Basic Total Ops | -0.15 | 0.25 | 0.21 | 0.38 | 0.38 |
| EPS Basic Continuous Ops | -0.15 | 0.25 | 0.21 | 0.38 | 0.38 |
| EPS Diluted Total Ops | -0.15 | 0.23 | 0.20 | 0.35 | 0.35 |
| EPS Diluted Continuous Ops | -0.15 | 0.22 | 0.18 | 0.33 | 0.33 |
| EBITDA(a) | $23,111 | $87,966 | $83,078 | $115,690 | $115,716 |